TherapeuticsMD Inc (TXMD) — Cash Flow-to-Debt Ratio
TherapeuticsMD Inc (TXMD) has a Cash Flow-to-Debt Ratio of 0.13x as of December 2025, meaning its operating cash flow of $1.37 Million could theoretically repay 0% of its total liabilities ($10.78 Million) in one year. See TherapeuticsMD Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
TherapeuticsMD Inc Cash Flow-to-Debt Ratio (1994–2025)
Historical debt coverage capacity for TherapeuticsMD Inc across 32 annual periods. Also explore TXMD net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for TherapeuticsMD Inc (1994–2025)
Year-by-year debt coverage analysis for TherapeuticsMD Inc. For market capitalisation and broader financial context, see TherapeuticsMD Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | $2.45 Million | $10.78 Million | ▲ +256.1% |
| 2024 | 0.06x | $732.00K | $11.45 Million | ▲ +101.9% |
| 2023 | -3.43x | $-48.14 Million | $14.02 Million | ▼ -4556.9% |
| 2022 | -0.07x | $-4.08 Million | $55.31 Million | ▲ +86.9% |
| 2021 | -0.56x | $-147.81 Million | $263.09 Million | ▼ -7.7% |
| 2020 | -0.52x | $-159.47 Million | $305.61 Million | ▲ +19.1% |
| 2019 | -0.65x | $-165.70 Million | $256.78 Million | ▲ +30.9% |
| 2018 | -0.93x | $-106.81 Million | $114.46 Million | ▲ +83.7% |
| 2017 | -5.72x | $-76.16 Million | $13.32 Million | ▼ -23.9% |
| 2016 | -4.61x | $-69.14 Million | $14.98 Million | ▲ +37.7% |
| 2015 | -7.41x | $-79.04 Million | $10.67 Million | ▼ -74.0% |
| 2014 | -4.26x | $-45.52 Million | $10.69 Million | ▼ -50.0% |
| 2013 | -2.84x | $-20.77 Million | $7.32 Million | ▼ -61.6% |
| 2012 | -1.76x | $-12.74 Million | $7.25 Million | ▼ -11.4% |
| 2011 | -1.58x | $-4.97 Million | $3.15 Million | ▼ -359.0% |
| 2010 | 0.61x | $836.83K | $1.37 Million | ▲ +269.3% |
| 2009 | -0.36x | $-417.34K | $1.16 Million | ▲ +90.3% |
| 2008 | -3.72x | $-133.00K | $35.72K | ▼ -184.2% |
| 2007 | 4.42x | $344.10K | $77.83K | ▲ +141.0% |
| 2006 | 1.83x | $329.84K | $179.83K | ▲ +119.4% |
| 2005 | 0.84x | $412.34K | $493.18K | ▼ -85.1% |
| 2004 | 5.60x | $207.73K | $37.12K | ▲ +28.4% |
| 2003 | 4.36x | $140.00K | $32.11K | ▼ -26.8% |
| 2002 | 5.96x | $100.08K | $16.80K | ▼ -15.3% |
| 2001 | 7.03x | $161.95K | $23.04K | ▼ -15.0% |
| 2000 | 8.27x | $133.97K | $16.21K | ▲ +203.3% |
| 1999 | 2.73x | $48.53K | $17.81K | ▲ +210.0% |
| 1998 | 0.88x | $44.60K | $50.72K | ▼ -92.1% |
| 1997 | 11.10x | $77.53K | $6.98K | ▼ -8.9% |
| 1996 | 12.19x | $58.78K | $4.82K | ▲ +1138.6% |
| 1995 | 0.98x | $63.45K | $64.49K | ▼ -84.5% |
| 1994 | 6.35x | $72.86K | $11.47K | — |